HK1137361A1 - Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor - Google Patents

Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor

Info

Publication number
HK1137361A1
HK1137361A1 HK10104843.9A HK10104843A HK1137361A1 HK 1137361 A1 HK1137361 A1 HK 1137361A1 HK 10104843 A HK10104843 A HK 10104843A HK 1137361 A1 HK1137361 A1 HK 1137361A1
Authority
HK
Hong Kong
Prior art keywords
kits
bone
methods
compositions therefor
correcting imbalance
Prior art date
Application number
HK10104843.9A
Other languages
English (en)
Inventor
Alain Moreau
Genevieve Mailhot
Original Assignee
Chu Sainte Justine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chu Sainte Justine filed Critical Chu Sainte Justine
Publication of HK1137361A1 publication Critical patent/HK1137361A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK10104843.9A 2007-02-15 2010-05-17 Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor HK1137361A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US89010007P 2007-02-15 2007-02-15
US91226707P 2007-04-17 2007-04-17
US91519607P 2007-05-01 2007-05-01
US93802507P 2007-05-15 2007-05-15
PCT/CA2008/000312 WO2008098379A1 (en) 2007-02-15 2008-02-15 Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor

Publications (1)

Publication Number Publication Date
HK1137361A1 true HK1137361A1 (en) 2010-07-30

Family

ID=39689600

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10104843.9A HK1137361A1 (en) 2007-02-15 2010-05-17 Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor

Country Status (12)

Country Link
US (2) US8129432B2 (xx)
EP (1) EP2120912B1 (xx)
JP (1) JP5485704B2 (xx)
KR (1) KR101394594B1 (xx)
CN (1) CN101677978B (xx)
AU (1) AU2008215081B2 (xx)
CA (1) CA2677703C (xx)
HK (1) HK1137361A1 (xx)
IL (1) IL200189A (xx)
MX (1) MX2009008704A (xx)
WO (1) WO2008098379A1 (xx)
ZA (1) ZA200905328B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108264568B (zh) * 2016-12-30 2021-11-16 博晟生医股份有限公司 重组多肽、核酸分子及其组合物以及制造、使用其的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151466A (en) * 1987-01-16 1992-09-29 Phadke Shrikant V Single step bulk process for high impact polyester masterbatches, products thereof and blends with polyesters
US5151446A (en) * 1989-09-25 1992-09-29 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
US5071875A (en) * 1989-09-25 1991-12-10 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
SE9101642D0 (sv) * 1991-05-30 1991-05-30 Kabi Pharmacia Ab Phospholipids
US5856124A (en) * 1994-06-17 1999-01-05 The General Hospital Corporation DNA encoding high-affinity melatonin receptors
FR2771739B1 (fr) * 1997-11-28 2001-04-20 Adir Nouveaux composes naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20050019841A1 (en) * 1999-05-14 2005-01-27 Arbor Vita Corporation Modulation of signaling pathways
EP1581648A2 (en) 2002-09-09 2005-10-05 Nura, Inc. G protein coupled receptors and uses thereof
US7365209B2 (en) * 2003-02-11 2008-04-29 Pharmacopeia, Inc. Nitrogen heterocycle biaryls for osteoporosis and other diseases
WO2005078455A1 (en) 2004-02-18 2005-08-25 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human melatonin receptor type 1a (mtnr1a)
WO2005078444A1 (en) 2004-02-18 2005-08-25 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human melatonin receptor type 1b (mtnr1b)

Also Published As

Publication number Publication date
AU2008215081B2 (en) 2013-07-18
CA2677703A1 (en) 2008-08-21
CA2677703C (en) 2014-08-05
IL200189A (en) 2015-01-29
US8129432B2 (en) 2012-03-06
EP2120912A1 (en) 2009-11-25
EP2120912B1 (en) 2013-04-03
EP2120912A4 (en) 2010-04-28
JP5485704B2 (ja) 2014-05-07
MX2009008704A (es) 2009-10-19
US8222298B2 (en) 2012-07-17
CN101677978A (zh) 2010-03-24
CN101677978B (zh) 2013-03-20
KR20090111335A (ko) 2009-10-26
WO2008098379A1 (en) 2008-08-21
KR101394594B1 (ko) 2014-05-14
ZA200905328B (en) 2010-04-28
AU2008215081A1 (en) 2008-08-21
IL200189A0 (en) 2010-04-15
US20120135930A1 (en) 2012-05-31
US20100029567A1 (en) 2010-02-04
JP2010518129A (ja) 2010-05-27

Similar Documents

Publication Publication Date Title
HK1255083A1 (zh) 用於治療肺動脈高壓的方法和組合物
EP2326335A4 (en) COMPOSITION FOR TISSUE REPAIR IMPLANT AND METHODS OF MAKING THE SAME
IL200889A0 (en) Compositions and kits for treating influenza
ZA200906390B (en) Compositions and methods for promoting bone development
IL198684A0 (en) Compositions and methods for bone formation and remodeling
SI2102224T2 (sl) Kristalinična oblika 1-(beta-D-glukopiranozil)-4-metil-3-(5-(4-fluorofenil)-2-tienilmetil) benzen hemihidrata
PT2101766T (pt) Composições e métodos de utilização de (r)-pramipexole
ZA200904408B (en) Dairy compositions and method of making
EP2334185A4 (en) COMPOSITIONS AND METHODS FOR USE OF (R) -PRAMIPEXOL
IL195725A0 (en) Polymorphous forms of carvedilol phosphate
ZA201000658B (en) Surgical kits and methods
EP2421543A4 (en) CEMENT COMPOSITION BASED ON BIPHASIC CALCIUM PHOSPHATE
PL2101766T3 (pl) Kompozycje i sposoby stosowania (R)-pramipeksolu
IL193271A0 (en) Modulation of bone formation
PT2402040T (pt) Composição de cimento ósseo, método para a produzir e kit para a produzir
IL200387A0 (en) Heterocylic compounds, compositions comprising them and methods of their use
ZA201003292B (en) Low-fat batter-like compositions and methods of preparing and using same
HK1151438A1 (en) Gas-effusing compositions and methods of making and using same
PL2262527T3 (pl) Kompozycje do osiągania w surowicy pożądanych poziomów glejowego czynnika wzrostu 2
EP2389205B8 (en) Method of making osteoinductive bone implant
GB0703525D0 (en) Method of making sweetner compositions
EP2361077A4 (en) MULTI-SOLUTION BONE CEMENTS AND METHODS OF MAKING SAME
GB0517933D0 (en) Repair of bone defects
EP2307548A4 (en) METHODS AND COMPOSITIONS FOR PROMOTING BONE GROWTH
HK1137361A1 (en) Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200215